Ozcan Yildiz

Ozcan Yildiz is an oncologist at Medipol Mega University Hospital in Istanbul. He treats solid tumors and blood-related malignancies. Dr. Yildiz has published 15 articles in international journals on neuroendocrine tumors and personalized cancer therapies.

Specialization and Clinical Focus

Dr. Yildiz treats various oncological conditions using targeted therapy. His primary areas of expertise include:

• Gastroenteropancreatic neuroendocrine tumors
• Breast, lung, and colorectal cancers
• Gastrointestinal malignancies including pancreatic and stomach cancer
• Gynecological cancers such as ovarian and uterine tumors
• Genitourinary cancers involving the prostate, bladder, and kidneys
• Hematological conditions like idiopathic thrombocytopenia — a disorder characterized by low platelet counts that lead to easy bruising or bleeding

The doctor performs chemotherapy, hormonal therapy, and radiotherapy. He also treats paraneoplastic syndromes and treatment-induced side effects.

Academic Background and Training

• 2007 – Istanbul University Cerrahpasa Faculty of Medicine – Specialty in Medical Oncology
• 2007 – Istanbul Taksim Training and Research Hospital – Specialty in Internal Medicine
• 1995 – Istanbul University Faculty of Medicine – Medical Degree

Research and Scientific Contributions

Dr. Yildiz has published over 15 articles in international journals. His research covers lipid-lowering treatments and cardiac function in metabolic disorders. He frequently publishes in journals including:

• Medical Oncology
• Journal of Endocrinological Investigation
• International Journal of Cardiology
• Gynecologic Oncology
• International Journal of Gynecological Cancer
• Swiss Medical Weekly

The specialist contributes case reports on rare conditions like metastatic primitive neuroectodermal tumors. He also investigates paraneoplastic pemphigus and gestational choriocarcinoma.

Professional Memberships

The doctor is an active member of professional bodies in oncology and hematology. These affiliations help him integrate clinical protocols into his practice at Medipol Hospital.